Nineteen (70.4%) patients had a GH-secreting macroadenoma (> 1 cm), 7 patients had a microadenoma (≤ 1 cm) and 1 patient had a GH-releasing hormone–producing bronchial intermediate-grade neuroendocrine tumor (NET). The gene discussed is GH1; the disease is neuroendocrine neoplasm.